Login to BlackFacts.com using your favorite Social Media Login. Click the appropriate button below and you will be redirected to your Social Media Website for confirmation and then back to Blackfacts.com once successful.
Enter the email address and password you used to join BlackFacts.com. If you cannot remember your login information, click the “Forgot Password” link to reset your password.
The Medicines Control Authority of Zimbabwe has announced the approval of the use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis for HIV prevention, a first for Africa.
